▶ 調査レポート

世界のH3N2感染症治療市場規模・現状・予測（2021年-2027年）
• 英文タイトル：Global H3N2 Infection Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のH3N2感染症治療市場規模・現状・予測（2021年-2027年） / Global H3N2 Infection Treatment Market Size, Status and Forecast 2021-2027 / QFJ1-4277資料のイメージです。• レポートコード：QFJ1-4277
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、120ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Multi User￥877,500 (USD5,850)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
QYResearch社発行の本調査レポートでは、H3N2感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（APP-309、アスピダセプト、C-05、CR-8020、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・H3N2感染症治療の市場動向
・企業の競争状況、市場シェア
・H3N2感染症治療の種類別市場規模と予測2016-2027（APP-309、アスピダセプト、C-05、CR-8020、その他）
・H3N2感染症治療の用途別市場規模と予測2016-2027（クリニック、病院、その他）
・H3N2感染症治療の北米市場規模2016-2027（アメリカ、カナダ）
・H3N2感染症治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・H3N2感染症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・H3N2感染症治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・H3N2感染症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AIMM Therapeutics B.V.、Aphios Corporation、Crucell N.V.、CSL Limited、Glide Pharmaceutical Technologies Limited、ILiAD Biotechnologies, LLC、Inovio Pharmaceuticals, Inc.、Johnson & Johnson、Medicago Inc.、MedImmune, LLC、Mucosis B.V.、NanoViricides, Inc.、Novavax, Inc.、OPKO Health, Inc.、Sarepta Therapeutics, Inc.、Takeda Pharmaceutical Company Limited、Visterra, Inc.、Zydus Cadila Healthcare Limited）
・結論

Market Analysis and Insights: Global H3N2 Infection Treatment Market
The global H3N2 Infection Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global H3N2 Infection Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global H3N2 Infection Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global H3N2 Infection Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global H3N2 Infection Treatment market.

Global H3N2 Infection Treatment Scope and Market Size
H3N2 Infection Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global H3N2 Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
APP-309
Aspidasept
C-05
CR-8020
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AIMM Therapeutics B.V.
Aphios Corporation
Crucell N.V.
CSL Limited
Glide Pharmaceutical Technologies Limited
ILiAD Biotechnologies, LLC
Inovio Pharmaceuticals, Inc.
Johnson & Johnson
Medicago Inc.
MedImmune, LLC
Mucosis B.V.
NanoViricides, Inc.
Novavax, Inc.
OPKO Health, Inc.
Sarepta Therapeutics, Inc.
Takeda Pharmaceutical Company Limited
Visterra, Inc.
Zydus Cadila Healthcare Limited

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global H3N2 Infection Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 APP-309
1.2.3 Aspidasept
1.2.4 C-05
1.2.5 CR-8020
1.2.6 Others
1.3 Market by Application
1.3.1 Global H3N2 Infection Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global H3N2 Infection Treatment Market Perspective (2016-2027)
2.2 H3N2 Infection Treatment Growth Trends by Regions
2.2.1 H3N2 Infection Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 H3N2 Infection Treatment Historic Market Share by Regions (2016-2021)
2.2.3 H3N2 Infection Treatment Forecasted Market Size by Regions (2022-2027)
2.3 H3N2 Infection Treatment Industry Dynamic
2.3.1 H3N2 Infection Treatment Market Trends
2.3.2 H3N2 Infection Treatment Market Drivers
2.3.3 H3N2 Infection Treatment Market Challenges
2.3.4 H3N2 Infection Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top H3N2 Infection Treatment Players by Revenue
3.1.1 Global Top H3N2 Infection Treatment Players by Revenue (2016-2021)
3.1.2 Global H3N2 Infection Treatment Revenue Market Share by Players (2016-2021)
3.2 Global H3N2 Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by H3N2 Infection Treatment Revenue
3.4 Global H3N2 Infection Treatment Market Concentration Ratio
3.4.1 Global H3N2 Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by H3N2 Infection Treatment Revenue in 2020
3.5 H3N2 Infection Treatment Key Players Head office and Area Served
3.6 Key Players H3N2 Infection Treatment Product Solution and Service
3.7 Date of Enter into H3N2 Infection Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 H3N2 Infection Treatment Breakdown Data by Type
4.1 Global H3N2 Infection Treatment Historic Market Size by Type (2016-2021)
4.2 Global H3N2 Infection Treatment Forecasted Market Size by Type (2022-2027)

5 H3N2 Infection Treatment Breakdown Data by Application
5.1 Global H3N2 Infection Treatment Historic Market Size by Application (2016-2021)
5.2 Global H3N2 Infection Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America H3N2 Infection Treatment Market Size (2016-2027)
6.2 North America H3N2 Infection Treatment Market Size by Type
6.2.1 North America H3N2 Infection Treatment Market Size by Type (2016-2021)
6.2.2 North America H3N2 Infection Treatment Market Size by Type (2022-2027)
6.2.3 North America H3N2 Infection Treatment Market Size by Type (2016-2027)
6.3 North America H3N2 Infection Treatment Market Size by Application
6.3.1 North America H3N2 Infection Treatment Market Size by Application (2016-2021)
6.3.2 North America H3N2 Infection Treatment Market Size by Application (2022-2027)
6.3.3 North America H3N2 Infection Treatment Market Size by Application (2016-2027)
6.4 North America H3N2 Infection Treatment Market Size by Country
6.4.1 North America H3N2 Infection Treatment Market Size by Country (2016-2021)
6.4.2 North America H3N2 Infection Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe H3N2 Infection Treatment Market Size (2016-2027)
7.2 Europe H3N2 Infection Treatment Market Size by Type
7.2.1 Europe H3N2 Infection Treatment Market Size by Type (2016-2021)
7.2.2 Europe H3N2 Infection Treatment Market Size by Type (2022-2027)
7.2.3 Europe H3N2 Infection Treatment Market Size by Type (2016-2027)
7.3 Europe H3N2 Infection Treatment Market Size by Application
7.3.1 Europe H3N2 Infection Treatment Market Size by Application (2016-2021)
7.3.2 Europe H3N2 Infection Treatment Market Size by Application (2022-2027)
7.3.3 Europe H3N2 Infection Treatment Market Size by Application (2016-2027)
7.4 Europe H3N2 Infection Treatment Market Size by Country
7.4.1 Europe H3N2 Infection Treatment Market Size by Country (2016-2021)
7.4.2 Europe H3N2 Infection Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific H3N2 Infection Treatment Market Size (2016-2027)
8.2 Asia-Pacific H3N2 Infection Treatment Market Size by Type
8.2.1 Asia-Pacific H3N2 Infection Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific H3N2 Infection Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific H3N2 Infection Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific H3N2 Infection Treatment Market Size by Application
8.3.1 Asia-Pacific H3N2 Infection Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific H3N2 Infection Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific H3N2 Infection Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific H3N2 Infection Treatment Market Size by Region
8.4.1 Asia-Pacific H3N2 Infection Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific H3N2 Infection Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America H3N2 Infection Treatment Market Size (2016-2027)
9.2 Latin America H3N2 Infection Treatment Market Size by Type
9.2.1 Latin America H3N2 Infection Treatment Market Size by Type (2016-2021)
9.2.2 Latin America H3N2 Infection Treatment Market Size by Type (2022-2027)
9.2.3 Latin America H3N2 Infection Treatment Market Size by Type (2016-2027)
9.3 Latin America H3N2 Infection Treatment Market Size by Application
9.3.1 Latin America H3N2 Infection Treatment Market Size by Application (2016-2021)
9.3.2 Latin America H3N2 Infection Treatment Market Size by Application (2022-2027)
9.3.3 Latin America H3N2 Infection Treatment Market Size by Application (2016-2027)
9.4 Latin America H3N2 Infection Treatment Market Size by Country
9.4.1 Latin America H3N2 Infection Treatment Market Size by Country (2016-2021)
9.4.2 Latin America H3N2 Infection Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa H3N2 Infection Treatment Market Size (2016-2027)
10.2 Middle East & Africa H3N2 Infection Treatment Market Size by Type
10.2.1 Middle East & Africa H3N2 Infection Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa H3N2 Infection Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa H3N2 Infection Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa H3N2 Infection Treatment Market Size by Application
10.3.1 Middle East & Africa H3N2 Infection Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa H3N2 Infection Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa H3N2 Infection Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa H3N2 Infection Treatment Market Size by Country
10.4.1 Middle East & Africa H3N2 Infection Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa H3N2 Infection Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AIMM Therapeutics B.V.
11.1.1 AIMM Therapeutics B.V. Company Details
11.1.2 AIMM Therapeutics B.V. Business Overview
11.1.3 AIMM Therapeutics B.V. H3N2 Infection Treatment Introduction
11.1.4 AIMM Therapeutics B.V. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.1.5 AIMM Therapeutics B.V. Recent Development
11.2 Aphios Corporation
11.2.1 Aphios Corporation Company Details
11.2.2 Aphios Corporation Business Overview
11.2.3 Aphios Corporation H3N2 Infection Treatment Introduction
11.2.4 Aphios Corporation Revenue in H3N2 Infection Treatment Business (2016-2021)
11.2.5 Aphios Corporation Recent Development
11.3 Crucell N.V.
11.3.1 Crucell N.V. Company Details
11.3.2 Crucell N.V. Business Overview
11.3.3 Crucell N.V. H3N2 Infection Treatment Introduction
11.3.4 Crucell N.V. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.3.5 Crucell N.V. Recent Development
11.4 CSL Limited
11.4.1 CSL Limited Company Details
11.4.2 CSL Limited Business Overview
11.4.3 CSL Limited H3N2 Infection Treatment Introduction
11.4.4 CSL Limited Revenue in H3N2 Infection Treatment Business (2016-2021)
11.4.5 CSL Limited Recent Development
11.5 Glide Pharmaceutical Technologies Limited
11.5.1 Glide Pharmaceutical Technologies Limited Company Details
11.5.2 Glide Pharmaceutical Technologies Limited Business Overview
11.5.3 Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Introduction
11.5.4 Glide Pharmaceutical Technologies Limited Revenue in H3N2 Infection Treatment Business (2016-2021)
11.5.5 Glide Pharmaceutical Technologies Limited Recent Development
11.6 ILiAD Biotechnologies, LLC
11.6.1 ILiAD Biotechnologies, LLC Company Details
11.6.2 ILiAD Biotechnologies, LLC Business Overview
11.6.3 ILiAD Biotechnologies, LLC H3N2 Infection Treatment Introduction
11.6.4 ILiAD Biotechnologies, LLC Revenue in H3N2 Infection Treatment Business (2016-2021)
11.6.5 ILiAD Biotechnologies, LLC Recent Development
11.7 Inovio Pharmaceuticals, Inc.
11.7.1 Inovio Pharmaceuticals, Inc. Company Details
11.7.2 Inovio Pharmaceuticals, Inc. Business Overview
11.7.3 Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Introduction
11.7.4 Inovio Pharmaceuticals, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.7.5 Inovio Pharmaceuticals, Inc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson H3N2 Infection Treatment Introduction
11.8.4 Johnson & Johnson Revenue in H3N2 Infection Treatment Business (2016-2021)
11.8.5 Johnson & Johnson Recent Development
11.9 Medicago Inc.
11.9.1 Medicago Inc. Company Details
11.9.2 Medicago Inc. Business Overview
11.9.3 Medicago Inc. H3N2 Infection Treatment Introduction
11.9.4 Medicago Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.9.5 Medicago Inc. Recent Development
11.10 MedImmune, LLC
11.10.1 MedImmune, LLC Company Details
11.10.2 MedImmune, LLC Business Overview
11.10.3 MedImmune, LLC H3N2 Infection Treatment Introduction
11.10.4 MedImmune, LLC Revenue in H3N2 Infection Treatment Business (2016-2021)
11.10.5 MedImmune, LLC Recent Development
11.11 Mucosis B.V.
11.11.1 Mucosis B.V. Company Details
11.11.2 Mucosis B.V. Business Overview
11.11.3 Mucosis B.V. H3N2 Infection Treatment Introduction
11.11.4 Mucosis B.V. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.11.5 Mucosis B.V. Recent Development
11.12 NanoViricides, Inc.
11.12.1 NanoViricides, Inc. Company Details
11.12.2 NanoViricides, Inc. Business Overview
11.12.3 NanoViricides, Inc. H3N2 Infection Treatment Introduction
11.12.4 NanoViricides, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.12.5 NanoViricides, Inc. Recent Development
11.13 Novavax, Inc.
11.13.1 Novavax, Inc. Company Details
11.13.2 Novavax, Inc. Business Overview
11.13.3 Novavax, Inc. H3N2 Infection Treatment Introduction
11.13.4 Novavax, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.13.5 Novavax, Inc. Recent Development
11.14 OPKO Health, Inc.
11.14.1 OPKO Health, Inc. Company Details
11.14.2 OPKO Health, Inc. Business Overview
11.14.3 OPKO Health, Inc. H3N2 Infection Treatment Introduction
11.14.4 OPKO Health, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.14.5 OPKO Health, Inc. Recent Development
11.15 Sarepta Therapeutics, Inc.
11.15.1 Sarepta Therapeutics, Inc. Company Details
11.15.2 Sarepta Therapeutics, Inc. Business Overview
11.15.3 Sarepta Therapeutics, Inc. H3N2 Infection Treatment Introduction
11.15.4 Sarepta Therapeutics, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.15.5 Sarepta Therapeutics, Inc. Recent Development
11.16 Takeda Pharmaceutical Company Limited
11.16.1 Takeda Pharmaceutical Company Limited Company Details
11.16.2 Takeda Pharmaceutical Company Limited Business Overview
11.16.3 Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Introduction
11.16.4 Takeda Pharmaceutical Company Limited Revenue in H3N2 Infection Treatment Business (2016-2021)
11.16.5 Takeda Pharmaceutical Company Limited Recent Development
11.17 Visterra, Inc.
11.17.1 Visterra, Inc. Company Details
11.17.2 Visterra, Inc. Business Overview
11.17.3 Visterra, Inc. H3N2 Infection Treatment Introduction
11.17.4 Visterra, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021)
11.17.5 Visterra, Inc. Recent Development
11.18 Zydus Cadila Healthcare Limited
11.18.1 Zydus Cadila Healthcare Limited Company Details
11.18.2 Zydus Cadila Healthcare Limited Business Overview
11.18.3 Zydus Cadila Healthcare Limited H3N2 Infection Treatment Introduction
11.18.4 Zydus Cadila Healthcare Limited Revenue in H3N2 Infection Treatment Business (2016-2021)
11.18.5 Zydus Cadila Healthcare Limited Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global H3N2 Infection Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of APP-309
Table 3. Key Players of Aspidasept
Table 4. Key Players of C-05
Table 5. Key Players of CR-8020
Table 6. Key Players of Others
Table 7. Global H3N2 Infection Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global H3N2 Infection Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global H3N2 Infection Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global H3N2 Infection Treatment Market Share by Regions (2016-2021)
Table 11. Global H3N2 Infection Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global H3N2 Infection Treatment Market Share by Regions (2022-2027)
Table 13. H3N2 Infection Treatment Market Trends
Table 14. H3N2 Infection Treatment Market Drivers
Table 15. H3N2 Infection Treatment Market Challenges
Table 16. H3N2 Infection Treatment Market Restraints
Table 17. Global H3N2 Infection Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global H3N2 Infection Treatment Market Share by Players (2016-2021)
Table 19. Global Top H3N2 Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H3N2 Infection Treatment as of 2020)
Table 20. Ranking of Global Top H3N2 Infection Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by H3N2 Infection Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players H3N2 Infection Treatment Product Solution and Service
Table 24. Date of Enter into H3N2 Infection Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global H3N2 Infection Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global H3N2 Infection Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global H3N2 Infection Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global H3N2 Infection Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global H3N2 Infection Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global H3N2 Infection Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global H3N2 Infection Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America H3N2 Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America H3N2 Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America H3N2 Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America H3N2 Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America H3N2 Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe H3N2 Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe H3N2 Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe H3N2 Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe H3N2 Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe H3N2 Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific H3N2 Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific H3N2 Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific H3N2 Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific H3N2 Infection Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific H3N2 Infection Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America H3N2 Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America H3N2 Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America H3N2 Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America H3N2 Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America H3N2 Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa H3N2 Infection Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa H3N2 Infection Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa H3N2 Infection Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa H3N2 Infection Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa H3N2 Infection Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa H3N2 Infection Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. AIMM Therapeutics B.V. Company Details
Table 65. AIMM Therapeutics B.V. Business Overview
Table 66. AIMM Therapeutics B.V. H3N2 Infection Treatment Product
Table 67. AIMM Therapeutics B.V. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 68. AIMM Therapeutics B.V. Recent Development
Table 69. Aphios Corporation Company Details
Table 70. Aphios Corporation Business Overview
Table 71. Aphios Corporation H3N2 Infection Treatment Product
Table 72. Aphios Corporation Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 73. Aphios Corporation Recent Development
Table 74. Crucell N.V. Company Details
Table 75. Crucell N.V. Business Overview
Table 76. Crucell N.V. H3N2 Infection Treatment Product
Table 77. Crucell N.V. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 78. Crucell N.V. Recent Development
Table 79. CSL Limited Company Details
Table 80. CSL Limited Business Overview
Table 81. CSL Limited H3N2 Infection Treatment Product
Table 82. CSL Limited Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 83. CSL Limited Recent Development
Table 84. Glide Pharmaceutical Technologies Limited Company Details
Table 85. Glide Pharmaceutical Technologies Limited Business Overview
Table 86. Glide Pharmaceutical Technologies Limited H3N2 Infection Treatment Product
Table 87. Glide Pharmaceutical Technologies Limited Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 88. Glide Pharmaceutical Technologies Limited Recent Development
Table 89. ILiAD Biotechnologies, LLC Company Details
Table 90. ILiAD Biotechnologies, LLC Business Overview
Table 91. ILiAD Biotechnologies, LLC H3N2 Infection Treatment Product
Table 92. ILiAD Biotechnologies, LLC Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 93. ILiAD Biotechnologies, LLC Recent Development
Table 94. Inovio Pharmaceuticals, Inc. Company Details
Table 95. Inovio Pharmaceuticals, Inc. Business Overview
Table 96. Inovio Pharmaceuticals, Inc. H3N2 Infection Treatment Product
Table 97. Inovio Pharmaceuticals, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 98. Inovio Pharmaceuticals, Inc. Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 102. Johnson & Johnson Recent Development
Table 103. Medicago Inc. Company Details
Table 104. Medicago Inc. Business Overview
Table 105. Medicago Inc. H3N2 Infection Treatment Product
Table 106. Medicago Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 107. Medicago Inc. Recent Development
Table 108. MedImmune, LLC Company Details
Table 109. MedImmune, LLC Business Overview
Table 110. MedImmune, LLC H3N2 Infection Treatment Product
Table 111. MedImmune, LLC Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 112. MedImmune, LLC Recent Development
Table 113. Mucosis B.V. Company Details
Table 114. Mucosis B.V. Business Overview
Table 115. Mucosis B.V. H3N2 Infection Treatment Product
Table 116. Mucosis B.V. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 117. Mucosis B.V. Recent Development
Table 118. NanoViricides, Inc. Company Details
Table 119. NanoViricides, Inc. Business Overview
Table 120. NanoViricides, Inc. H3N2 Infection Treatment Product
Table 121. NanoViricides, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 122. NanoViricides, Inc. Recent Development
Table 123. Novavax, Inc. Company Details
Table 124. Novavax, Inc. Business Overview
Table 125. Novavax, Inc. H3N2 Infection Treatment Product
Table 126. Novavax, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 127. Novavax, Inc. Recent Development
Table 128. OPKO Health, Inc. Company Details
Table 129. OPKO Health, Inc. Business Overview
Table 130. OPKO Health, Inc. H3N2 Infection Treatment Product
Table 131. OPKO Health, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 132. OPKO Health, Inc. Recent Development
Table 133. Sarepta Therapeutics, Inc. Company Details
Table 134. Sarepta Therapeutics, Inc. Business Overview
Table 135. Sarepta Therapeutics, Inc. H3N2 Infection Treatment Product
Table 136. Sarepta Therapeutics, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 137. Sarepta Therapeutics, Inc. Recent Development
Table 138. Takeda Pharmaceutical Company Limited Company Details
Table 139. Takeda Pharmaceutical Company Limited Business Overview
Table 140. Takeda Pharmaceutical Company Limited H3N2 Infection Treatment Product
Table 141. Takeda Pharmaceutical Company Limited Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 142. Takeda Pharmaceutical Company Limited Recent Development
Table 143. Visterra, Inc. Company Details
Table 144. Visterra, Inc. Business Overview
Table 145. Visterra, Inc. H3N2 Infection Treatment Product
Table 146. Visterra, Inc. Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 147. Visterra, Inc. Recent Development
Table 148. Zydus Cadila Healthcare Limited Company Details
Table 149. Zydus Cadila Healthcare Limited Business Overview
Table 150. Zydus Cadila Healthcare Limited H3N2 Infection Treatment Product
Table 151. Zydus Cadila Healthcare Limited Revenue in H3N2 Infection Treatment Business (2016-2021) & (US$ Million)
Table 152. Zydus Cadila Healthcare Limited Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global H3N2 Infection Treatment Market Share by Type: 2020 VS 2027
Figure 2. APP-309 Features
Figure 3. Aspidasept Features
Figure 4. C-05 Features
Figure 5. CR-8020 Features
Figure 6. Others Features
Figure 7. Global H3N2 Infection Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. H3N2 Infection Treatment Report Years Considered
Figure 12. Global H3N2 Infection Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global H3N2 Infection Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global H3N2 Infection Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global H3N2 Infection Treatment Market Share by Regions (2022-2027)
Figure 16. Global H3N2 Infection Treatment Market Share by Players in 2020
Figure 17. Global Top H3N2 Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H3N2 Infection Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by H3N2 Infection Treatment Revenue in 2020
Figure 19. Global H3N2 Infection Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global H3N2 Infection Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America H3N2 Infection Treatment Market Share by Type (2016-2027)
Figure 23. North America H3N2 Infection Treatment Market Share by Application (2016-2027)
Figure 24. North America H3N2 Infection Treatment Market Share by Country (2016-2027)
Figure 25. United States H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe H3N2 Infection Treatment Market Share by Type (2016-2027)
Figure 29. Europe H3N2 Infection Treatment Market Share by Application (2016-2027)
Figure 30. Europe H3N2 Infection Treatment Market Share by Country (2016-2027)
Figure 31. Germany H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific H3N2 Infection Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific H3N2 Infection Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific H3N2 Infection Treatment Market Share by Region (2016-2027)
Figure 41. China H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America H3N2 Infection Treatment Market Share by Type (2016-2027)
Figure 49. Latin America H3N2 Infection Treatment Market Share by Application (2016-2027)
Figure 50. Latin America H3N2 Infection Treatment Market Share by Country (2016-2027)
Figure 51. Mexico H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa H3N2 Infection Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa H3N2 Infection Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa H3N2 Infection Treatment Market Share by Country (2016-2027)
Figure 57. Turkey H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE H3N2 Infection Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AIMM Therapeutics B.V. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 61. Aphios Corporation Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 62. Crucell N.V. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 63. CSL Limited Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 64. Glide Pharmaceutical Technologies Limited Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 65. ILiAD Biotechnologies, LLC Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 66. Inovio Pharmaceuticals, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 67. Johnson & Johnson Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 68. Medicago Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 69. MedImmune, LLC Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 70. Mucosis B.V. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 71. NanoViricides, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 72. Novavax, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 73. OPKO Health, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 74. Sarepta Therapeutics, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 75. Takeda Pharmaceutical Company Limited Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 76. Visterra, Inc. Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 77. Zydus Cadila Healthcare Limited Revenue Growth Rate in H3N2 Infection Treatment Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

以下、関連資料のご紹介
  • 世界の皮膚・軟部組織感染症治療市場規模・現状・予測（2021年-2027年）
    Global Skin and Soft Tissue Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4865 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、皮膚・軟部組織感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、抗真菌剤、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、...
  • 世界のボツリヌス菌感染症治療市場規模・現状・予測（2021年-2027年）
    Global Clostridium Botulinum Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4028 2021年6月 97Pages
    QYResearch社発行の本調査レポートでは、ボツリヌス菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗毒素療法、細心気道管理、人工呼吸補助）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...
  • 世界の小児HIV感染症治療市場規模・現状・予測（2021年-2027年）
    Global Pediatric HIV Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-5935 2021年6月 96Pages
    QYResearch社発行の本調査レポートでは、小児HIV感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（無症状、軽症、中症、重症）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、ドラッグストア、その他）、主要地域別市場規模（北米、...
  • 世界のブドウ球菌感染症治療市場規模・現状・予測（2021年-2027年）
    Global Staphylococcal Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4899 2021年6月 100Pages
    QYResearch社発行の本調査レポートでは、ブドウ球菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射液）、用途別市場規模（黄色ブドウ球菌感染症、表皮ブドウ球菌感染症、サプロコッカス感染症）、主要地域別市場規模（北米、アメ...
  • 世界の羊膜感染症治療市場規模・現状・予測（2021年-2027年）
    Global Intra-amniotic Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-5807 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、羊膜感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ゲンタマイシン、クリンダマイシン、メトロニダゾール、その他）、用途別市場規模（病院・専門クリニック、外来手術センター、病院薬局、小売薬局、...
  • 世界のスポロトリクスシェンキー感染症治療市場規模・現状・予測（2021年-2027年）
    Global Sporothrix Schenckii Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4897 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、スポロトリクスシェンキー感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イトラコナゾール薬、アムホテリシンB薬、ヨウ化カリウム飽和溶液（SSKI）、手術、その他）、用途別市場規模（病院、専門...
  • 世界の上気道感染症治療市場規模・現状・予測（2021年-2027年）
    Global Upper Respiratory Tract Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-6058 2021年6月 98Pages
    QYResearch社発行の本調査レポートでは、上気道感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、非ステロイド性抗炎症薬 (NSAIDs) ＆鼻充血除去薬、その他）、用途別市場規模（鼻炎、副鼻腔炎、鼻咽頭炎、喉頭蓋炎、喉頭炎...
  • 世界の緑膿菌感染症治療市場規模・現状・予測（2021年-2027年）
    Global Pseudomonas Aeruginosa Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-5322 2021年6月 99Pages
    QYResearch社発行の本調査レポートでは、緑膿菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経鼻、経口、静脈内）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...
  • 世界の腹腔内感染症治療薬市場規模・現状・予測（2021年-2027年）
    Global Intra-abdominal Infection Treatment Drugs Market Size, Status and Forecast 2021-2027
    QFJ1-4387 2021年6月 105Pages
    QYResearch社発行の本調査レポートでは、腹腔内感染症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クロラムフェニコール、ベータラクタム、キノロン、アミノグリコシド、その他）、用途別市場規模（腹腔内膿瘍、虫垂炎、憩室炎、下痢、食中毒、...
  • 世界の多剤耐性細菌感染症治療市場規模・現状・予測（2021年-2027年）
    Global Multiple Drug Resistance Bacterial Infection Treatment Market Size, Status and Forecast 2021-2027
    QFJ1-4533 2021年6月 117Pages
    QYResearch社発行の本調査レポートでは、多剤耐性細菌感染症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（クリティカル、ミディアム、ハイ）、用途別市場規模（セファロスポリン、ベータラクタム、ベータラクタマーゼ阻害剤、オキサゾリジノン、環...